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Contrast mediaAbstract Introduction: Contrast-induced nephropathy is a leading cause of morbidity and mortal-
ity in high-risk patients.
Aim: To study different risk predictors of contrast induced nephropathy, among diabetic patients
with normal serum creatinine undergoing cardiac catheterization.
Patients and methods: It involved 250 consecutive diabetic patients who underwent either coronary
angiography or PCI. All patients were subjected to thorough history taking and clinical examina-
tion, measurement of serial serum creatinine levels and creatinine clearance prior to the procedure,
72 h after and after 7 days, coronary angiography or percutaneous coronary intervention, ECG,
echocardiography, follow up during the ﬁrst seventy-two hours for occurrence of contrast-induced
nephropathy, follow up one month later for occurrence of major adverse cardiac events.
Results: 58 patients developed CINwith total incidence of 23.2%. CINwas found to bemore among
the patients who had PCI (40 patients, 69%, P< 0.01). Regarding different predictors of CIN, age,
diabetes, ACEIs, anemia, lower LVEF, contrast media volume and lower creatinine clearance, were
signiﬁcantly associated with CIN (P< 0.01). Regarding MACE, only 4 patients had complications,
with an incidence of 3.4% vs 1.04% among CIN positive and negative patients, respectively.
Conclusion: Creatinine clearance or estimated GFR are important surrogates for assessment of kid-
ney function among diabetic patients undergoing catheterization despite normal serum creatinine.
Modiﬁable risk predictors of CIN should be corrected as possible. Prophylaxis against CIN should
be carried out by adequate hydration to all diabetic patients with calculation of the volume of contrast
in relation to CrCl or GFR.
ª 2014 Production and hosting by Elsevier B.V. on behalf of Egyptian Society of Cardiology.1. Introduction
Contrast-induced nephropathy is a leading cause of morbidity
and mortality in high-risk patients undergoing any procedure
250 T. Zaki et al.involving the use of radiographic contrast media.1 Subjects
who develop this complication have higher rates of mortality,
longer hospital stays and worse long-term outcomes.2 The
occurrence of contrast-induced nephropathy is related to the
number of the patients’ co-existing clinical risk factors. Among
the many risk factors, pre-existing renal impairment, advanc-
ing age, the presence of diabetes mellitus as well as the volume
and type of contrast agent administered are the most impor-
tant.1 The precise pathophysiologic mechanisms responsible
for the development of contrast-induced nephropathy are com-
plex and incompletely understood. At present, the only avail-
able tool for reducing the risk of developing contrast-
induced nephropathy is prevention. This can be achieved by
means of adequate peri-procedural hydration, using N-acetyl
cysteine as well as the selection of low osmolar or iso-osmolar
contrast agents in the least amount possible. Other agents are
still being tested for this purpose as well.3
2. Aim of study
To study different risk predictors of contrast induced nephrop-
athy, among diabetic patients with normal serum creatinine
undergoing cardiac catheterization. To follow up the occur-
rence of major adverse cardiac events (mortality, reinfarction,
stroke, target vessel revascularization) during one month of
hospital discharge.
3. Methods
3.1. Study population
The study was conducted on 250 consecutive patients present-
ing to the Ain Shams University Hospital catheter lab from the
period of September 2012 till November 2012 to undergo
either coronary angiography or percutaneous coronary inter-
vention. Exclusion criteria were: serum creatinine level
P1.5 mg/dL, recent exposure to radiographic contrast within
forty-eight hours of the study, allergy to radiographic contrast,
administration of N-acetyl cysteine, dopamine, mannitol or
theophylline during the intended time of the study and patient
known to have skeletal muscle disease or myopathy.
3.2. Methods
3.2.1. The suitable patients were subjected to the following
3.2.1.1. Thorough history taking. A full medical history was
taken with special emphasis on: the indication of the coronary
angiography, history of diabetes mellitus (recognized by the
patient giving symptoms suggestive of diabetes mellitus [as
polyuria, polydipsia, polyphagia, loss of weight, etc. . .]
and/or the patient’s receiving treatment for diabetes mellitus,
whether it were insulin or oral hypoglycemic drugs), history
of pre-existing renal impairment (recognized by symptoms sug-
gestive of the disease as oliguria, pruritus, anorexia, hiccups,
peripheral neuropathy, etc. . .) or by an elevated serum creati-
nine level, history of allergy to radiographic contrast media,
age and sex of the patient (for purpose of calculation of the
creatinine clearance level using the Cockroft–Gault equation).
3.2.1.2. Physical examination. Complete general and local
examination with special emphasis on: weight and height ofthe patient (for purpose of calculation of the creatinine clear-
ance level using the Cockroft–Gault equation), features and
skin complexion (in search for evidence suggestive of pre-exist-
ing chronic renal impairment) as: yellow–brown complexion,
pallor, itching marks. . .etc.
3.2.1.3. Twelve-lead surface ECG. To identify evidence of any
of the following: an old myocardial infarction, ST-T segment
deviations suggestive of ischemia, chamber enlargements, con-
duction disturbances and rhythm disturbances.
3.2.1.4. Coronary angiography. Coronary angiography was
done in the standard fashion after gaining femoral artery
access puncture using Seldinger’s technique. The standard cor-
onary views were obtained, which included an average six left
coronary and two right coronary artery injections giving sufﬁ-
cient data to enable quantitative angiography. The type of con-
trast used was Ioversol (Optiray 300) which is low osmolar
non ionic contrast media.
3.2.1.5. Assessment of serial serum creatinine levels. A baseline
venous sample was withdrawn prior to the procedure as well as
two other samples, one of which was collected 72 h after the
procedure and the other 7 days after the procedure.
It was assessed using a fully automated analyzer Biolis 24i
Premium manufactured by Tokyo Boeki Medical Systems.
3.2.1.6. Assessment of serial creatinine clearance levels. The glo-
merular ﬁltration rate (GFR) is an index of functioning renal
mass and it is the best measure of overall kidney function in
health and disease.4 Normal glomerular ﬁltration rates are
120 ± 25 ml/min for males, and 95 ± 20 ml/min for females.5
The use of prediction equations to estimate GFR from serum
creatinine and other variables (age, sex, race, and body size)
is therefore recommended by the National Kidney Foundation
for the diagnosis and stratiﬁcation of chronic kidney diseases.6
According to this foundation, renal function is moderately
decreased if GFR is <60 ml/min 1.73 m2 and severely
decreased if GFR is<30 ml/min 1.73 m2. The proposed equa-
tions are the Cockroft–Gault formula,7 as recommended by the
American Diabetes Association,8 and the Modiﬁcation of Diet
in Renal Disease (MDRD) study equation. The more recent
MDRD equation seems more accurate9, but it has not been val-
idated in diabetic kidney disease. Its superiority over the Cockr-
oft–Gault formula has been mentioned in some, but not all
recent reports.10 A commonly used surrogate marker for esti-
mate of creatinine clearance is the –Gault formula, which in
turn estimates GFR in ml/min.4 It is named after the scientists
who ﬁrst published the formula, and it employs serum creati-
nine measurements and a patient’s weight to predict the creat-
inine clearance.11 The formula, as originally published, is:
GFR= (140  age) · weight (kg)/(72 · serum creatinine)
in women, multiplied by 0.85. This formula expects weight
to be measured in kilograms and creatinine to be measured
in mg/dL, as is standard in the USA.3.3. End point
The patients were observed during the forty-eight hours of fol-
low up. It has to be noted that the third sample was mostly
obtained on an outpatient basis. The primary end point was
Table 1 Baseline demographic characteristics, risk factors
and LV EF of the study groups.
Mean age (years) 57.73 ± 7.50
Males No. (%) 162 (64.8%)
Females No. (%) 88 (35.2%)
Mean body weight (kg) 89.42 ± 10.33
Mean height (cm) 166.20 ± 4.39
Smoking No. (%) 134 (53.6%)
Family history No. (%) 32 (12.8%)
Hypertension No. (%) 70 (27%)
Median duration of diabetes
mellitus (years)
8
Oral hypoglycemic drugs No. (%) 78 (31.2)
Insulin no (%) 172 (68.8)
NSAIDs 8 (3.2%)
ACEIs 88 (35.2%)
Anemia 10 (4%)
LV EF 30–69% (mean: 50.52%)
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charge one month follow up was done to all patients among
our study. They were subjected to either clinical visits or phone
calls in order to assess the possible occurrence of major adverse
cardiac events (mortality, stroke, reinfarction, target vessel
revascularization) and occurrence of renal failure and subse-
quent dialysis.
3.4. Data management
Data were collected, coded, revised and entered into the statis-
tical package for social science (SPSS) version (17) and the fol-
lowing were done. The qualitative data were presented as
number and percentages while the quantitative data were pre-
sented as mean, standard deviations and ranges. The compar-
ison between two groups with qualitative data was done by
using Chi-square test and/or Fisher exact test only when the
expected count was less than 5 in any cell. The comparison
between two groups with quantitative data was done by using
Independent sample t-test. The receiver operating characteris-
tic curve (ROC) was used to assess the cut-off point between
two groups with sensitivity, speciﬁcity, positive predictive
value and negative predictive value. Logistic regression analy-
sis was used to assess the risk factors for CIN with odds ratio.
The conﬁdence interval was set to 95% and the margin of error
accepted was set to 5%. So, the p-value of <0.05 was consid-
ered signiﬁcant. P value >0.05 = Non-signiﬁcant (NS), P
value <0.05 = Signiﬁcant (S) and P value <0.01 = Highly
signiﬁcant (HS).
4. Results
This is a cross sectional study that was conducted on 250 dia-
betic patients referred to the Ain Shams University Hospital
Catheter Lab to undergo either coronary angiography or
PCI. They all had serum creatinine levels within the normal
range and no history of preexisting renal disease. No preproce-
dural prophylactic measures against CIN were taken. 158
patients had coronary angiography while 92 patients had
PCI, of which 14 primary PCI were done with a successful
outcome.
4.1. Baseline demographic characteristics, risk factors and LV
systolic function
The age and sex distribution among our study group showed
162 male patients (64.8%) and 88 female patients (35.2%) with
age ranging from 40 to 82 years and mean ± SD of
57.73 ± 7.50 years. While the body weight mean ± SD
89.42 ± 10.33 kg and height mean ± SD 166.20 ± 4.39 cm.
There were 134 smoker patients (53.6%). 32 patients (12.8%)
had a positive family history of ischemic heart disease. They
were all type II diabetic patients, 78 patients were receiving
oral hypoglycemics, while 158 patients were receiving insulin
treatment. No one was on diet regimen with a median duration
of eight years. There were 70 hypertensive patients (27%), ver-
sus 180 (72%) patients not known to be hypertensive. Patients
receiving angiotensin converting enzyme inhibitors were 88
patients. Patients receiving NSAID were eight patients only
of the study group. We considered patients having hemoglobin
level less than 11 g/dl as anemic patients. They were ten anemicpatients among our study group. The mean EF among the
patients was 50.52% with the least EF measured 30% and
the maximum was 69% (Table 1).
4.2. Baseline S. Creatinine and creatinine clearance
Baseline creatinine clearance was calculated using the
Cockroft–Gault equation. The minimum baseline S. Creatinine
value during the study was 0.6 and the maximum was
1.4 mg/dl while the mean was 0.87 mg/dl among the study
population. After 72 h of contrast administration the maximum
S. Creatinine reached 2.5 mg/dl, while the mean was 1.14 mg/dl.
The starting mean ± SD baseline creatinine clearance of
the patients preprocedural, was 118.64 ml/min ± 34.69
while the minimum CrCl was 49.68 ml/min and the
maximum 220.95 ml/min. Creatinine clearance measured
using Cockroft–Gault equation 72 h post procedural revealed
a mean ± SD of 95.88 ± 36.37 and minimum of 31.37 and
maximum of 220.95 as shown in Table 2.
4.3. Volume of contrast in relation to eGFR
The mean amount of contrast used was 165.88 ± 88.88 cc. The
minimum amount was 70 cc while the maximum amount used
was 400 cc during a primary PCI case. We calculated the vol-
ume of contrast in relation to eGFR preprocedural as a predic-
tor of CIN among the study population showing a mean of
1.57 ± 1.09 ml/min.
The patients were classiﬁed according to their creatinine
clearance into different groups:
 >90 ml/min indicting normal GFR 196 patients (78.4%).
 60–89 mild renal impairment, 46 patients (18.4%).
 30–59 moderate renal impairment; 8 patients (3.2%).
 No patients had CrCl less than 30 ml/min.
4.4. Incidence of CIN among the study group
The deﬁnition of contrast induced nephropathy adopted in
our study is increase in the serum creatinine P0.5 mg/dl from
the baseline value within 48–72 h after contrast media
Table 2 Serial measurements of S. Creatinine and CrCl.
Minimum Maximum Mean SD
Volume of contrast (cc) 70 400 165.88 88.88
Baseline S. Creatinine mg/dl 0.6 1.4 0.87 0.20
S. Creatinine day 3 (mg/dl) 0.6 2.5 1.14 0.41
S. Creatinine day 7 (mg/dl) 0.5 2.3 0.98 0.31
CrCl day 1 (eGFR) 49.68 220.95 118.64 34.69
CrCl day 3 31.37 220.95 95.88 36.67
CrCl day 7 25.92 227.33 108.30 35.89
Volume of contrast /e GFR 0.41 6.64 1.57 1.09
Table 3 Incidence of CIN among coronary angiography and PCI patients.
Angio/PCI CIN Chi-square test
Negative Positive
No. % No. % X2 P-value
Coronary angiography 140 72.90 18 31.00 33.596 <0.01
Percutaneous coronary intervention 52 27.10 40 69.00
Total 192 100.00 58 100.00
252 T. Zaki et al.administration. We found that 58 patients developed CIN with
a total incidence of 23.2%. CIN was found to be more among
the patients who had PCI, they were 40 patients (69%). It was
less among the coronary angiography patients as they were
only 18 patients (31%), showing a highly statistically signiﬁ-
cant P value of less than 0.01 as shown in Table 3.
The occurrence of CIN was even more signiﬁcant among
the patients presenting with acute myocardial infarction
requiring primary PCI. There were 14 patients who had pri-
mary PCI of which 10 developed CIN, yielding a highly signif-
icant relation between having primary PCI and developing
CIN showing a highly statistically signiﬁcant P value <0.01.
4.5. Different predictors of CIN
4.5.1. Gender
We did not ﬁnd a correlation between the gender and develop-
ment of CIN among our study group. A total of 162 male
patients were involved, of which only 34 patients developed
CIN. A total of 88 female patients were involved, of which
only 24 of them developed CIN with incidence of 41.40%,
resulting in a non statistically signiﬁcant P value of 0.26.
4.5.2. Age
We found a strong correlation between increasing age as a
predictor of developing CIN. Using the receiver operator
characteristic curve analysis we deﬁned a good cut off value
of 57 years as a predictor for CIN, patients above this age
developed CIN more than those below that age as shown in
Fig. 1 with a sensitivity of 73.33% and speciﬁcity of 67.74%.
Among the 58 patients who developed CIN, 42 patients were
above the age of 57 and 16 less than it showing a highly statis-
tically signiﬁcant P value <0.01.
4.5.3. Smoking
We could not ﬁnd a correlation between smoking as a risk fac-
tor for CAD and possible development of CIN. Out of 58patients who developed CIN, 30 patients were smokers and
28 were not. A P value of 0.7 was considered statistically
non signiﬁcant.
4.5.4. Family history of ischemic heart disease
We did not ﬁnd a correlation between patients who had posi-
tive family history of ischemic heart disease as a risk of CAD,
and as a risk predictor for development of CIN among our
study group. We found only six patients having a positive fam-
ily history of ischemic heart disease among all patients who
developed CIN. A P value of 0.5 was considered non
signiﬁcant.
4.5.5. Diabetes
All the patients presented in our study were Type II diabetic
patients. We intended to see the relation between patients on
oral hypoglycemic drugs and those on insulin in relation to
CIN occurrence. We found that patients on insulin treatment
were signiﬁcant risk predictor for CIN. Fifty-two patients
(89.7%) were on insulin treatment among all the patients
who developed CIN, while only six patients were on OHG
and developed CIN.
4.5.6. Hypertension
We could not ﬁnd a correlation between hypertension and
development of CIN, with a non signiﬁcant P value of 0.5.
On the contrary patients who were hypotensive, deﬁned as
having a systolic blood pressure less than 100 mmHg preproce-
dural, were a strong risk predictor for development of CIN
with a highly statistically signiﬁcant P value of <0.01.
4.5.7. Drugs
Patients who were receiving angiotensin converting enzyme
inhibitors either as a treatment of heart failure or as a treat-
ment for hypertension were higher among those who devel-
oped CIN. There were 36 patients (62.10%) on regular
angiotensin converting enzyme inhibitor treatment who
Figure 1 ROC curve showing cutoff value of 57 years as a
predictor for CIN.
Clinical predictors of CIN among diabetic patients 253developed CIN while 22 patients (37.9%) were not on ACE
treatment and developed CIN. The use of NSAID was limited
only to eight patients, four of them developed CIN, they were
receiving ibuprofen on regular intervals. They did not show a
correlation as a predictor for developing CIN with non statis-
tically signiﬁcant P value of 0.068.
4.5.8. Anemia
The mean hemoglobin level tends to be lower among the
patients who developed CIN which was 12.67 g/dl ± 1.22
SD while among the other group it was 13.53 mg/dl ± 1.07
SD showing a highly statistically signiﬁcant P value <0.01.
Among the study group we deﬁned anemia as having hemoglo-
bin less than 11 g/dl. We found a total of 10 anemic patients of
which 5 developed CIN with a statistically signiﬁcant P value
of 0.04.
4.5.9. Ejection fraction
Patients having a lower ejection fraction tend to have increased
risk of CIN compared to those with better ejection fraction
with a highly statistically signiﬁcant P value <0.01. The mean
ejection fraction among patients who developed CIN was
43.45%± 7.98 while those who did not develop CIN had a
mean EF of 52.66%± 6.91. Patients having EF <50% were
more to develop CIN in comparison to those who were
>50% with a highly statistically signiﬁcant P value of <0.01.Table 4 Serial serum creatinine and CrCl in relation to CIN patien
CIN
Negative P
Mean SD M
S. Creatinine day 1 0.82 0.17
S. Creatinine day 3 0.97 0.24
S. Creatinine day 7 0.86 0.16
CrCl 1 125.63 32.34 9
CrCl 3 108.04 32.00 5
CrCl 7 119.49 30.99 74.5.10. Contrast volume
The mean contrast volume used among patients who devel-
oped CIN was 240.69 ± 104.86 cc while it was
143.28 ± 69.30 cc among patients who did not. We found a
strong correlation between increasing the volume of contrast
and increasing the risk of developing CIN. Those patients
receiving more than 200 cc of contrast media had a higher inci-
dence (65.5%) among CIN patients in comparison to patients
using less than 200 cc of contrast who had an incidence of
34.5% among CIN positive patients.4.5.11. Creatinine clearance
We calculated the creatinine clearance according to the –Gault
equation and we used it as an indirect measure to estimate the
glomerular ﬁltration rate and we assumed that it will be more
accurate to asses the kidney function using it rather than using
the standard S. Creatinine. As we started with patients having
normal S. Creatinine, they did not receive any prophylactic
measures against CIN. We found that almost eight patients
had CrCl less than 60 ml/min indicating a moderate degree
of renal impairment. It showed that patients having lower
CrCl were higher among the CIN group with a highly statisti-
cally signiﬁcant P value <0.01 as shown in Tables 4 and 5.4.6. Volume of contrast in relation to eGFR
In recent studies the Volume of contrast in relation to eGFR
was used as independent predictor of CIN. We aimed to ﬁnd
the relation between the increasing ratio of it and the increas-
ing the risk of CIN and to some extent having a cut off value at
which we can use and implement in clinical practice. The mean
V/eGFR was 2.69 ± 1.35 among patients who developed CIN
in comparison to 1.23 ± 0.70 in patients who did not showing
a highly statistically signiﬁcant P value < 0.01. Using the
ROC curve we identiﬁed a cut off value of 2.7 as a ratio in
PCI patients with a speciﬁcity of 85.19% and sensitivity of
65% (Fig .2). We could not use this value in coronary angiog-
raphy patients due to the relative decrease in total amount of
contrast used among these patients.
4.7. Risk of CIN in relation to extent of CAD
We found a higly signiﬁcant correlation, as patients who had
more than one vessel treated had a higher risk for developing
CIN comparing to those who had only single vessel treated.
The increasing number of stents used had a strong correlation
with further risk of CIN as patients who had 3 stents or morets.
Independent t-test
ositive T p-value
ean SD
1.00 0.24 6.048 <0.01
1.69 0.39 16.861 <0.01
1.35 0.38 14.024 <0.01
5.50 32.29 6.219 <0.01
5.63 17.17 11.952 <0.01
1.62 24.71 10.761 <0.01
Table 5 Relation between preprocedural creatinine clearance at day one and CIN.
CrCl preprocedure CIN Chi-square test
Negative Positive X2 P-value
No % No %
P60 (ml/min) 192 100.00 50 86.20 27.358 <0.01
<60 (ml/min) 0 0.00 8 13.80
Total 192 100.00 58 100.00
Figure 2 Cut-off point, sensitivity, speciﬁcity, for V/eGFR in
prediction of CIN patients.
Table 7 Morbidity and mortality among study group.
Outcome Total number
(n= 250)
CIN patients
(n= 58)
No CIN
(n= 192)
IABP 0 0 0
Renal failure 0 0 0
Stroke 2 1 1
Death 1 0 1
Reinfarction 1 1 0
Target vessel
revascularization
0 0 0
254 T. Zaki et al.had more risk than who had 2 stents or less. After we did a uni-
variate analysis, we found that risk predictors of CIN were
older patients who had PCI and received larger amounts of
contrast media, and hypotensive patients. In addition to those
patients receiving ACE, patients receiving NSAID, lower EF
were also at a higher risk. Patients having greater extent of
CAD revealed by multivessel affection and increased number
of vessels treated and stents used were also signiﬁcant predic-
tors of CIN. We intended to do a multivariate analysis among
different predictors as shown in Table 6 revealing that patients
who were hypotensive and anemic, had no correlation as a pre-
dictor of CIN.Table 6 Logistic regression analysis for prediction of CIN.
Variable Coeﬃcient Std. err
Coronary angiography /PCI 1.9195 0.37
Age >57 1.5259 0.37
Treatment of Diabetes (insulin) 1.4931 0.46
Hypotension SBP <100 mmHg 20.6234 2180.79
ACE 1.5844 0.36
Anemia HGB <11 0.9919 0.78
Contrast volume P200 cc 2.0218 0.37
V/eGFR P2.7 2.9957 0.54
Number of vessels treated 2.0794 0.45
Number of stents 1.9915 0.474.8. Morbidity and mortality
Follow up of MACE for one month among patients presented
in our study was done either by clinical appointments or phone
calls upon which detailed history was taken regarding these
possible complications. We found only 4 patients who had
complications, with an incidence of 3.4% vs 1.04% among
CIN positive and negative patients, respectively, as shown in
Table 7.
We found that CIN was regressive in 34 patients (58.6%).
After one week we found that 24 patients still had an increase
in serum creatinine P1.5 mg/dl.
5. Discussion
Contrast induced nephropathy is most commonly deﬁned as a
rise in the serum creatinine level of at least 0.5 mg/dL within
48–72 h of contrast medium administration.12 The incidence
of CIN in the general population has been calculated to be
<2%. In high-risk patients, i.e., patients with chronic renal
impairment, diabetes mellitus, congestive heart failure, and
older age, the incidence has been calculated to be >20–30%.13or P Odds ratio 95% CI
22 <0.0001 6.8177 3.29–14.141
57 <0.0001 4.5991 2.20–9.61
8 0.0014 4.4511 1.78–11.14
4 0.9925 0.000 0.00–0.00
01 <0.0001 4.8765 2.42–9.88
34 0.2055 2.6964 0.58–12.52
19 <0.0001 7.5521 3.64–15.65
7 <0.0001 20 6.85–58.44
15 <0.0001 8 3.30–19.38
08 <0.0001 7.3262 2.91–18.43
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patients taken consecutively with no history of pre existing
renal disease who had normal serum creatinine. They were
subjected to cardiac catheterization, 158 patients had coronary
angiography while 92 patients had PCI of which 14 patients
presented with acute myocardial infarction and required pri-
mary intervention. They all received low osmolar, non ionic
contrast media. We adopted a single deﬁnition of CIN which
is increase in the baseline S. Creatinine valueP0.5 mg/dl after
48–72 of contrast administration.
CIN among the study group was found to be 23% which is
considered to be relatively high. We can contribute this high
incidence to all patients being type 2 diabetics, having no pro-
phylaxis against CIN although having multiple risk factors.
Larger amounts of contrast used especially among patients
having PCI and complex intervention in addition to those hav-
ing primary PCI. Although patients presented with normal S.
Creatinine we found 21% having preprocedural impairment in
their eGFR with 8 patients below 60 ml/min and 46 patients
having eGFR between 60 and 90 ml/min.
This is similar to what was reached by Wang et al.14 who
conducted their study on 114 diabetic patients undergoing elec-
tive PCI through radial approach and found it to be 18.4%.
This high incidence could be related to some of their patients
who already had elevated baseline S. Creatinine >1.5 mg/dl.
On the contrary, El Etriby et al.15 who studied the frequency
and predictors of CIN among 169 type 2 diabetic patients in an
Egyptian cohort undergoing cardiac catheterization found that
overall incidence of CIN was 8.87%, with an incidence of CIN
among patients with normal S. Creatinine 3.33% and among
those who had preexisting renal disease 22.44%. This relatively
low overall incidence could be attributed to giving hydration
intravenously to all patients undergoing cardiac catheterization
and excluding those having primary PCI. All their patients who
developed CIN had CrCl <55 ml/min even though patients
who had normal baseline S. Creatinine and developed CIN.
Another study was conducted by Eric et al.16 who found the
incidence of CIN 7.3% among a total of 3036 patients, with
normal baseline S. Creatinine <1.5 undergoing PCI. Although
the same type of contrast was used, which was low osmolar non
ionic, this low incidence could be contributed to having only
1090 diabetic patients among their study (35.9%). These
patients had only elective PCI with preprocedural hydration.
On the same side Yong et al.17 found an incidence of 9% of
CIN among their study of 277 consecutive patients undergoing
primary PCI, they used low osmolar non ionic contrast and
iso-osmolar non ionic contrast and preprocedure hydration
was carried out among all the patients.
We studied the age as a risk predictor of CIN and we found
that older patients >57 years were at higher risk of developing
CIN (OR 4.5; 95% CI 2.2–9.6) with P value <0.01 using mul-
tivariate analysis. The same was reached by Eric et al.16 as he
found that age was a signiﬁcant independent risk predictor for
CIN (odds ratio 6.4; 95% CI, 1.01–13.3) with a statistically sig-
niﬁcant P value = 0.042. That was concordant with Yong
et al.17 who found almost the same result with patients older
than 65 years were signiﬁcantly associated with CIN. Same
results were reached by El Etriby et al.15 who found that
patients were older among CIN group mean ± SD
62.1 ± 5.5 vs 55.9 ± 7.7 with a highly signiﬁcant P value
<0.01. This can be contributed to older patients who usually
have multiple comorbidities, longer diabetes duration,decrease in renal mass and perfusion and function, and con-
comitant extent of coronary artery disease, more difﬁcult vas-
cular access, preexisting renal impairment despite normal
serum creatinine.
In our study we could not have a correlation between
female gender and development of CIN showing a non signif-
icant P value of 0.261. This could be attributed to the small
sample size of the study. That was against Eric et al.16 who
studied 3036 patients and found that female gender was a
highly signiﬁcant predictor for CIN (OR, 2.0; 95% CI, 1.5–
2.7; p= 0.001), they contributed this to the fact that usually
they have lower eGFR despite normal S. Creatinine value.
As regards using the ejection fraction as risk predictor of
CIN we found in our study that patients having lower ejection
fraction mean ± SD 43.45 ± 7.98% were among the patients
who developed CIN, with a highly signiﬁcant P value <0.01.
We considered EF of 50% as a cutoff value using ROC curve
analysis. Patients below that ﬁgure showed a highly signiﬁcant
predictor of CIN (OR, 5.398; 95% CI, 3.134–9.164; P value
<0.01) which was concordant with a study by Eric et al.16
who found that abnormal LV EF <50% was a signiﬁcant risk
predictor for development of CIN (OR, 1.02; 95% CI, 1.01–
1.04; P value = 0.01). We can contribute this to LV dysfunc-
tion results in low effective intravascular volume leading to
renal hypoperfusion, in addition to concomitant use of ACE
and diuretics among this population. The same was reached
by El Etriby et al.15 who concluded in their study that patients
who presented with congestive heart failure had been at risk to
develop CIN with a highly signiﬁcant P value < 0.01. They
did not take into consideration the actual ejection fraction of
the patients; instead they considered the clinical symptoms
and signs of congestive heart failure.
In the context of assessing anemia as a risk predictor of
CIN, we could not ﬁnd by multivariate logistic regression anal-
ysis a correlation between anemia and CIN, deﬁned by hemo-
globin level less than 11 g/dl with a P value of 0.2. It could be
due to the small sample size and due to not taking into consid-
eration the hematocrit level of the patients, in addition to the
fact that anemia was a signiﬁcant risk in patients who already
had moderate renal impairment as stated by Mehran et al.2.
On the contrary Eric et al.16 found that anemia with hemoglo-
bin less than 11 g/dl was a signiﬁcant risk predictor of CIN
(OR1.5; 95% CI, 1.01–2.2; P value = 0.044). Mehran and
Nikolsky18 found that lower baseline hematocrit was identiﬁed
as an independent predictor of CIN regardless of the presence
or absence of chronic kidney disease, each 3% decrease in
baseline hematocrit resulted in a signiﬁcant increase in the
odds of CIN in patients with and without chronic kidney dis-
ease (11% and 23%, respectively).
In our study we found that hypotension deﬁned as having
systolic blood pressure <100 mmHg was a non signiﬁcant pre-
dictor of CIN using multivariate analysis with a non-signiﬁ-
cant P value of 0.9. On the contrary Eric et al.16 found that
systolic hypotension with blood pressure <100 mmHg was a
signiﬁcant predictor (OR, 1.5; 95% CI 1.01–2.2; p= 0.004).
It is well known that hypotension results in marked renal
hypoperfusion augmenting the toxic effect of contrast and
increasing medullary ischemia. We can conclude that the dif-
ference in the results was related to the small sample size
among our study.
Among our study we found that diabetic patients receiving
insulin therapy were at high risk for development of CIN by
256 T. Zaki et al.using multivariate analysis which showed a highly signiﬁcant
statistically P value of 0.0014 (OR, 4.45; 95% CI 1.78–
11.14). The same was reached by Eric et al.16 who showed that
diabetics on insulin therapy were at highest risk compared to
diabetics on oral hypoglycemic P value of 0.001 due to rela-
tively longer duration of diabetes and they were associated
with more multivessel disease affection and decrease in their
renal function.
We calculated volume of contrast in relation to eGFR as a
predictor of CIN, we found a ratio >2.7 as fair discrimination
and as a predictor for CIN using ROC curve analysis. We used
it as an independent predictor of CIN with odds ratio of 20;
95% CI 6.85–58.44, P value <0.01 with a sensitivity of 65%
and speciﬁcity of 85% among diabetic patients with normal
serum creatinine undergoing PCI. We calculated eGFR using
the –Gault equation instead of using the MDRD equation.
Almost the same result was conducted by Tan et al.19, who
studied the volume of contrast in relation to creatinine clear-
ance as a predictor of CIN in patients undergoing PCI. Ratios
were obtained from 1140 consecutive patients undergoing
unselective PCI. ROC curve analysis indicated that a V/CrCl
ratio of 2.62 was a fair discriminator for CIN (odds ratio:
2.20; 95% conﬁdence interval: 1.00–4.81, P< 0.05). The same
was reached by Yong et al.17 who found that a V/eGFR ratio
>2.39 remained signiﬁcantly associated with CIN odds ratio
4.24, 95% conﬁdence interval 1.23–14.66, P value <0.05 and
is an independent predictor of CIN after primary PCI in
patients with STEMI showing a sensitivity of 72% and sensi-
tivity of 80% in detecting CIN. The eGFR in their study
was calculated using MDRD equation. All the ﬁgures were
relatively close to each other, and this could be explained by
using almost close volume of contrast, and the mean eGFR
of the patients was close to each other giving us almost the
same cut off value.
On the contrary Wang et al.14 found a higher cut off value
as he retrospectively investigated clinical factors associated
with the development of CIN in 114 diabetic patients who
had undergone elective PCI through radial approach. Stepwise
regression analysis showed that the V/eGFR ratio was a signif-
icant independent predictor for the development of CIN
(P= 0.001). At a cut-off point of >3.1, the V/eGFR ratio
exhibited 71% sensitivity and 70% speciﬁcity for detecting
CIN. This higher cutoff value could be contributed to the
different route of access used leading to a larger amount of
contrast among their study in association with the lower eGFR
and using the MDRD equation, they also used this value as an
early predictor of rise in serum creatinine after 24 h of contrast
administration.
It is noted that the increasing volume of contrast adminis-
tered is a signiﬁcant risk predictor of CIN. We found in our
study that the volume of contrast was among CIN positive
and negative patients, respectively (240.69 ± 104.86) ml vs.
(143.28 ± 69.30) ml, with a highly signiﬁcant P value <0.01.
We also found that patients receiving high contrast volume
P200 cc, were at a higher risk of developing CIN with a signif-
icant P value <0.01 (OR 7.5, 95% CI 3.64–15.65). This was
concordant with what El Etriby et al.15 found as increasing vol-
ume of contrast was a signiﬁcant risk predictor among PCI
patients (285 ± 63.9 vs 139.1 ± 46.6) with a P value <0.01.
The same was reached by Wang et al.14 who found a larger
amount of contrast among patients with CIN (253 ± 75 ml
vs 211 ± 71 ml) with a signiﬁcant P value of 0.017.While we calculated the preprocedural creatinine clearance
of the patients using the –Gault equation to give us a
better overall assessment of kidney function7 we found that
21% of the patients had renal impairment although having
normal baseline S. Creatinine <1.5 mg/dl. We found that
3.2% had moderate renal impairment with CrCl 30–59
ml/min and 18.4% had mild renal impairment with CrCl
60–89 ml/min. On the same lines Mujtaba et al.20 who assessed
renal insufﬁciency in patients with normal S. Creatinine under-
going Coronary Angiography in a Pakistani cohort found that
among total 693 patients 34.1% patients had eGFR <80
ml/min using the –Gault equation. They showed a signiﬁcant
correlation between increasing age and female gender with
decreases in eGFR despite normal S. Creatinine with a P value
of <0.01.
In our study patients with preprocedural decrease in creat-
inine clearance were more among the CIN patients
(95.50 ± 32.29) ml/min vs (125.63 ± 32.34) ml/min, P value
<0.01. We used a CrCl of 60 ml/min as cut off value showing
a signiﬁcant risk predictor for CIN. This shows that it will be
of great practice to assess kidney function prior to any proce-
dure by calculating the CrCl of the patient.
We found that patients on chronic use of ACE inhibitors as
either a treatment of heart failure or to control hypertension
had a highly signiﬁcant correlation with P value <0.001
(OR= 4.8, 95% CI 2.42–9.88). This could be due to the
decrease in renal perfusion by vasoconstriction of the afferent
arteriole. The same was reached by Barıs et al.21 who studied
the effects of chronic usage of angiotensin-converting enzyme
inhibitors and angiotensin receptor blockers on contrast-
induced nephropathy in low-risk patients among 295 patients.
CIN occurrence was signiﬁcantly higher in RAAS than no
RAAS group (17.5% vs. 7.4%, p= 0.01). Chronic RAAS
blocker administration was an independent predictor of CIN
(OR= 2.69; 95% CI: 1.025–7.067; p= 0.04). Also, Umruddin
et al.22, found that the odds ratio for development of CIN with
respect to ACEI or ARB use was 2.68 (95% conﬁdence inter-
val, 1.51–4.76 p< 0.001). They concluded that it is reasonable
to discontinue their use 48 h prior to exposure to radiocontrast
agents, especially in patients with multiple risk factors.
We tried to ﬁnd a relation between the extent of coronary
artery disease as a risk predictor of CIN. We found that
patients who had more multivessel affection on their coronary
angiogram were at higher risk of CIN especially those who had
more than one vessel treated (OR 8, 95%CI 3.3–19.38, P value
<0.01) and those who had three or more stents used (OR 7.32,
95% CI 2.91–18.43, P value < 0.01). The same was reached by
Wang et al.14, who found that the number of treated vessels
and the number of stents used were higher among the CIN
group, he assumed that such patients required longer time of
operation, larger volume of contrast and advised to have
staged PCI among patients who were at the highest risk.
On the contrary Yong et al.17 did not ﬁnd a relation
between the number of stents used and number of vessels trea-
ted as a risk predictor for CIN among their study on primary
PCI patients with a non-signiﬁcant P value of 0.37 and 0.309,
respectively. This could be related to treating only the culprit
lesion and usually requiring lesser number of stents used dur-
ing primary PCI than elective cases.
Regarding our follow up, we could not ﬁnd that CIN alone
caused mortality in this cohort of patients. We found that no
patients had renal failure or subsequent need of dialysis, two
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patient died. The incidence of complication was higher among
patients who developed CIN 3.4% vs 1.04%. We found that
one week after the procedure CIN was regressive in 34 patients
(58.6%), and 24 patients still had increase in S. Creatinine
being P1.5 mg/dl, we can assume that the rate of CIN
regression would be higher if we had in addition another
S. Creatinine sample after one month.
Eric et al.16 found that the mortality rate was signiﬁcantly
higher in CIN (+) patients compared to CIN () patients
(14.5% vs 1.1%) at 1 month and (17.8% vs 2.2%) at 6 months.
We can contribute these different statistical results to the large
number of CIN cases (222 patients) that were followed up for
more extended period of time reaching up to 6 months.
6. Summary
Contrast-induced nephropathy is a potentially avoidable
complication caused during procedures involving the use of
radiographic contrast media. All subjects, especially the high-
risk ones should be subjected to available preventive protocols
prior to and after such procedures. The current study was done
to evaluate different clinical risk predictors of contrast induced
nephropathy among diabetic patients not known to have pre-
existing renal disease and presenting with normal S. creatinine,
undergoing cardiac catheterization. The current study was
conducted on 250 patients presenting to the Cath Lab at Ain
Shams University Hospitals to undergo coronary angiography
or percutaneous coronary intervention for different indications
in the period between September 2012 and November 2012.
All patients were subjected to proper history taking, thorough
clinical examination, standard twelve-lead surface ECG and
coronary angiography or percutaneous coronary intervention.
Three venous samples were withdrawn from all patients before
the procedure, 72 h after the procedure and after 7 days.
Different risk factors: Age, sex, CrCl, ejection fraction, volume
of contrast, hypotension, hypertension, anemia, number of
vessels affected, number of vessels treated, number of stents
used, the use of NSAID and ACE. The current study found
that it is of utmost importance to depend on creatinine clear-
ance or estimated GFR as a surrogate for assessment of kidney
function among patients undergoing catheterization despite
normal serum creatinine. It was, however, concluded that
patients with diabetes were among the high risk patients for
development of CIN, despite normal kidney function. All
modiﬁable risk predictors of CIN should be determined prior
to any procedure of contrast administration especially among
those undergoing cardiac catheterization and should be cor-
rected as possible. Prophylaxis against CIN should be carried
out by adequate hydration to all diabetic patients undergoing
catheterization with adequate assessment of patient risk score
and calculation of the volume of contrast in relation to
estimated GFR or CrCl keeping in mind the different cut off
values predicted by different studies.7. Conclusion
Risk assessment should be done to all patients undergoing car-
diac catheterization even though they had normal serum creat-
inine. It is of utmost importance to assess patient kidney
function by either calculating creatinine clearance or estimatedGFR. All efforts should be done to correct all modiﬁable risk
predictors of CIN such as contrast volume, anemia and hypo-
tension and withdrawal of nephrotoxic medications prior to
the procedure. It is of value to use the volume in contrast in
relation to CrCl as a predictor of CIN. Subgroups of patients
with normal baseline Cr undergoing PCI are at risk of develop-
ing CIN. Age, female gender, insulin dependent diabetes
mellitus, presence of hypotension, anemia and low LVEF are
predictors of CIN. Prophylaxis may be considered in these
patients.
8. Recommendations
Preventive hydration, should be undertaken for all patients
undergoing any procedure involving the use of intravenous
contrast media.
Conﬂict of interest
Not only serum creatinine should be taken as a reference for
contrast induced nephropathy. Diabetic patients are at high
risk for developing contrast induced nephropathy. Subjects
who develop this complication have higher rates of mortality,
longer hospital stays and worse long-term outcomes. So, other
parameters such as creatinine clearance or estimated GFR
should be taken into consideration as a surrogate for assess-
ment of kidney function among patients undergoing catheter-
ization despite normal serum creatinine.
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